Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Shareholder vote results
  5. 3 Insider Initial Statement of Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. 8-K Event Other events
  11. 8-K Event Other events
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 12 of 18 · 348 filings